Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07122336

Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
384 (estimated)
Sponsor
Shanghai Chest Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The design of this study is an intervention, randomized, controlled study and contains three randomized groups:(1)PVI group;(2)PVI+PWI group;(3)PVI+PWI+EGM group.

Conditions

Interventions

TypeNameDescription
PROCEDUREPVIPVI
PROCEDUREPWIPWI
PROCEDUREEGMEGM

Timeline

Start date
2025-07-16
Primary completion
2025-12-31
Completion
2026-12-31
First posted
2025-08-14
Last updated
2025-08-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07122336. Inclusion in this directory is not an endorsement.

Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation (NCT07122336) · Clinical Trials Directory